Karl Pfleger, Agingbiotech.info | Longevity Investor Q&A Karl is a prolific angel investor of longevity companies and manages the agingbiotech.info website. Here he shares his insights into the longevity landscape. Key Takeaways: There’s been a recent resurgence of investment in longevity Because aging is not categorized as a disease, most aging companies are targeting conservative… Continue reading Karl Pfleger, Agingbiotech.info | Longevity Investor Q&A
Presenters Sonia Arrison, 100 Plus Capital Sonia Arrison is an entrepreneur, investor, and best-selling author. She is founder of 100 Plus Capital, Chair of the Alliance for Longevity Initiatives, advisor to Felicis Ventures, and advisor to Bioverge, which invests at the convergence of biology and technology…. Read More Progress on Health Extension in 2021 with… Continue reading Progress on Health Extension in 2021 with Sonia Arrison, 100 Plus Capital
Summary Reason works as CEO at Repair Biotechnologies, which is focused on reversing atherosclerosis. He’s also an active self-experimenter regarding aging interventions. Reason also spearheads some aging advocacy efforts – such as the blog fightaging.org. Presenters Reason, Fight Aging Reason is the founder and writer of Fight Aging!, a leading voice in the rejuvenation biotechnology… Continue reading Reason, Fight Aging | Q&A on How to Fight Aging
Presenters Sergey Young, Longevity Vision Fund – Longevity investor and visionary with a mission to extend the healthy lifespans of 1 billion people – Founder of the $100M Longevity Vision Fund—one of the few funds specializing exclusively in longevity and helping to accelerate longevity breakthroughs – Development Sponsor of Age Reversal XPRIZE, a global initiative… Continue reading Sergey Young, Longevity Vision Fund | Neil Littman, Bioverge | Longevity Investing
Summary Kristen Fortney discusses the Bioage platform and one of their most promising drugs. Bioage focuses on translating and analyzing human-derived molecular data to discover drug candidates that have already have clinical data and partial approval. Doing so allows them to rapidly bring drugs to market and focus on drugs which have the highest chance… Continue reading Kristen Fortney, Bioage | Building a pipeline of clinical-stage therapies to target aging
Summary David Furman describes the effect inflammation has on the aging process. Inflammaging – chronic inflammation which occurs as we age – takes center stage at the nexus of age related pathologies. A collaborative effort between the Buck Institute and Stanford reveals how inflammation can be measured and correlated with things like multimorbidity, aging, frailty,… Continue reading David Furman, Buck Inst. | Systems Immunology of Aging to Enable Precision Preventative Medicine
Summary In this session, Reason, co-founder and CEO of Repair Biotechnologies, offered a sneak peek into their product and technology – a Cholesterol Degrading Platform – enabled by genetically modified macrophages able to consume and degrade cholesterol plaques in arteries. Apart from showing promising results in mice, he also explained the mechanism of action based… Continue reading Atherosclerosis: The As Yet Undefeated Monster
Summary Dr. Emil Kendziorra and Aschwin De Wolf talk about the process in cryonics and cryopreservation of organs, especially brains. They also address doubts related to the damage that can be caused in the tissues of cryopreserved people, and overall dive into the state-of-the-art solutions and research in cryonics, foreshadowing what is going to be… Continue reading Emil Kendziorra & Aschwin De Wolf | Biostasis & Cryonics Q&A
Summary In this session, Alexander Fedintsev, co-founder of the Radical Life Extension biohacking group, came to discuss why biohacking is a necessary component for radical life extension, how they do biohacking in the RLE group (with a few tips for better and more scientific self-experimentation), what they already achieved (like their well-known plasmapheresis trial), and… Continue reading Alexander Fedintsev | Biohacking – A Necessary Component of a Strategy for Radical Life Extension
Summary In this session, Terrie Moffitt, professor at Duke University, and Daniel Belsky, assistant professor at Columbia University, dove into the details of a new approach to measuring aging using DNA methylation. Their Pace of Aging approach, based on which a second generation DunedinPACE algorithm was developed, looks at multiple timepoints and assesses how fast… Continue reading Daniel Belsky, Terrie Moffitt | The DunedinPoAm DNA Methylation Algorithm
